Yang et al. found that cytoplasmic HMGB1 reduced the sensitivity of CML cells to death induced by anticancer drugs by upregulating the autophagy pathway. Here, HMGB1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.